National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -10 of 13         results per page
View Search Criteria | Help With Results
           
Last Modified: 1/23/2007     First Published: 11/24/2002  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


Other


MRC-BR12
EU-20114, ISRCTN83176944, NCT00052455

Last Modified: 6/13/2008     First Published: 5/28/2004  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


3 to 21 at diagnosis


NCI


COG-ACNS0331
ACNS0331, NCT00085735

Last Modified: 12/20/2006     First Published: 1/13/2006  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


3 to 18


Other


GPOH-HIT-GBM-D
EU-205100, NCT00278278


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


60 and over


Other


CHUBX 2007/13
NCT00590837


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Other


2004-0595
NCT00527657

Last Modified: 11/7/2006     First Published: 3/1/2002  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


3 to 30 at initial diagnosis


Other


CHP-693
CHP-IRB-2001-12-2301, NCI-V01-1680, NCT00031590

Last Modified: 10/5/2007     First Published: 3/24/2003  

7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


3 and over


NCI


MSKCC-02088
NCT00058370

Last Modified: 12/11/2006     First Published: 12/22/2005  

8.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


3 to 18


Other


CCLG-CNS-2004-01
EU-20580, NCT00274911

Last Modified: 5/23/2007     First Published: 1/6/2006  

9.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


3 to 21


Other


CCLG-CNS-2001-06
EU-20577, NCT00276666


10.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Other


GFPC 05-01
NCT00418743

   
  Display for Print   New Search 1 2   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov